Youngjin Byun

Title: Youngjin Byun: Innovator in Pharmaceutical Composition

Introduction

Youngjin Byun is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of human mesenchymal stem cells. His innovative work has led to the development of a unique pharmaceutical composition that holds promise for various medical applications.

Latest Patents

Youngjin Byun holds a patent for a pharmaceutical composition containing human mesenchymal stem cells. This patent outlines a method for producing a frozen pharmaceutical composition prepared from cultured human mesenchymal stem cells. The method involves several steps, including the use of trypsin to detach cells, washing them with a bicarbonate Ringer's solution containing human serum albumin, and suspending the cells in a solution that allows for freezing. This innovative approach enhances the preservation and potential therapeutic use of stem cells.

Career Highlights

Youngjin Byun is associated with JCR Pharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the field of regenerative medicine, and he is recognized for his expertise in stem cell technology.

Collaborations

Youngjin Byun collaborates with esteemed colleagues, including Hiroyuki Shirono and Shoichiro Kamei. Their combined efforts contribute to the advancement of pharmaceutical innovations and the exploration of new therapeutic avenues.

Conclusion

Youngjin Byun's contributions to the field of pharmaceuticals, particularly through his patent on human mesenchymal stem cells, highlight his role as an innovator in medical science. His work continues to inspire advancements in regenerative medicine and offers hope for future treatments.